BEAT
BioTelemetry, Inc.
BEAT
BEAT
Delisted
BEAT was delisted on the 8th of February, 2021.
227 hedge funds and large institutions have $1.39B invested in BioTelemetry, Inc. in 2018 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 64 increasing their positions, 95 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 202 → 227 (+25)
33% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 95
Holders
227
Holding in Top 10
6
Calls
$23.1M
Puts
$13.4M
Top Buyers
| 1 | +$47.5M | |
| 2 | +$18M | |
| 3 | +$15.3M | |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
+$13.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.87M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$12.2M | |
| 3 | -$12M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$10M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.46M |